WO2004058809A3 - Novel essential bacterial polypeptides - Google Patents

Novel essential bacterial polypeptides Download PDF

Info

Publication number
WO2004058809A3
WO2004058809A3 PCT/CA2003/001934 CA0301934W WO2004058809A3 WO 2004058809 A3 WO2004058809 A3 WO 2004058809A3 CA 0301934 W CA0301934 W CA 0301934W WO 2004058809 A3 WO2004058809 A3 WO 2004058809A3
Authority
WO
WIPO (PCT)
Prior art keywords
bacterial polypeptides
essential bacterial
novel essential
novel
polypeptides
Prior art date
Application number
PCT/CA2003/001934
Other languages
French (fr)
Other versions
WO2004058809A2 (en
Inventor
Aled Edwards
Akil Dharamsi
Masoud Vedadi
Cheryl Arrowsmith
Cristina Virag
Dhushy Kanagarajah
Kamran Mansoury
Hui Ouyang
Simon Houston
Kristina Buzadzija
Megan Domagala
Ivy Ng
Rosanne Thalakada
Matthew Tai
Kathleen Nethery
Bryan Beattie
Dawn Richards
Veronica Canadien
Benjamin Pinder
Merry-Lynn Mcdonald
Muhammad Zahoor Alam
Original Assignee
Affinium Pharm Inc
Aled Edwards
Akil Dharamsi
Masoud Vedadi
Cheryl Arrowsmith
Cristina Virag
Dhushy Kanagarajah
Kamran Mansoury
Hui Ouyang
Simon Houston
Kristina Buzadzija
Megan Domagala
Ivy Ng
Rosanne Thalakada
Matthew Tai
Kathleen Nethery
Bryan Beattie
Dawn Richards
Veronica Canadien
Benjamin Pinder
Merry-Lynn Mcdonald
Muhammad Zahoor Alam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharm Inc, Aled Edwards, Akil Dharamsi, Masoud Vedadi, Cheryl Arrowsmith, Cristina Virag, Dhushy Kanagarajah, Kamran Mansoury, Hui Ouyang, Simon Houston, Kristina Buzadzija, Megan Domagala, Ivy Ng, Rosanne Thalakada, Matthew Tai, Kathleen Nethery, Bryan Beattie, Dawn Richards, Veronica Canadien, Benjamin Pinder, Merry-Lynn Mcdonald, Muhammad Zahoor Alam filed Critical Affinium Pharm Inc
Priority to AU2003287824A priority Critical patent/AU2003287824A1/en
Publication of WO2004058809A2 publication Critical patent/WO2004058809A2/en
Publication of WO2004058809A3 publication Critical patent/WO2004058809A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
PCT/CA2003/001934 2002-12-26 2003-12-19 Novel essential bacterial polypeptides WO2004058809A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003287824A AU2003287824A1 (en) 2002-12-26 2003-12-19 Novel essential bacterial polypeptides

Applications Claiming Priority (28)

Application Number Priority Date Filing Date Title
US43655102P 2002-12-26 2002-12-26
US43658702P 2002-12-26 2002-12-26
US43656302P 2002-12-26 2002-12-26
US60/436,587 2002-12-26
US60/436,551 2002-12-26
US60/436,563 2002-12-26
US43698102P 2002-12-30 2002-12-30
US43700702P 2002-12-30 2002-12-30
US43716702P 2002-12-30 2002-12-30
US60/437,167 2002-12-30
US60/436,981 2002-12-30
US60/437,007 2002-12-30
US43761802P 2002-12-31 2002-12-31
US43753202P 2002-12-31 2002-12-31
US43761702P 2002-12-31 2002-12-31
US43755202P 2002-12-31 2002-12-31
US43764002P 2002-12-31 2002-12-31
US43754402P 2002-12-31 2002-12-31
US43727402P 2002-12-31 2002-12-31
US43746402P 2002-12-31 2002-12-31
US60/437,640 2002-12-31
US60/437,274 2002-12-31
US60/437,544 2002-12-31
US60/437,617 2002-12-31
US60/437,552 2002-12-31
US60/437,532 2002-12-31
US60/437,618 2002-12-31
US60/437,464 2002-12-31

Publications (2)

Publication Number Publication Date
WO2004058809A2 WO2004058809A2 (en) 2004-07-15
WO2004058809A3 true WO2004058809A3 (en) 2005-02-24

Family

ID=32686480

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2003/001934 WO2004058809A2 (en) 2002-12-26 2003-12-19 Novel essential bacterial polypeptides

Country Status (2)

Country Link
AU (1) AU2003287824A1 (en)
WO (1) WO2004058809A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101487719B1 (en) 2006-05-16 2015-01-29 페르가뭄 아베 Improved antimicrobial peptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ASOH S ET AL: "Nucleotide sequence of the pbpA gene and characteristics of the deduced amino acid sequence of penicillin-binding protein 2 of Escherichia coli K12.", EUROPEAN JOURNAL OF BIOCHEMISTRY / FEBS. 15 OCT 1986, vol. 160, no. 2, 15 October 1986 (1986-10-15), pages 231 - 238, XP009035325, ISSN: 0014-2956 *
DATABASE EMBL [online] 19 September 1987 (1987-09-19), XP002292596, retrieved from EBI Database accession no. X04516 *
DATABASE EMBL 1 November 1988 (1988-11-01), XP002292597, retrieved from EBI Database accession no. P05850 *
EDWARDS A M ET AL: "PROTEIN PRODUCTION: FEEDING THE CRYSTALLOGRAPHERS AND NMR SPECTROSCOPISTS", NATURE STRUCTURAL BIOLOGY, NEW YORK, NY, US, vol. 7, no. SUPPL, November 2000 (2000-11-01), pages 970 - 972, XP001154099, ISSN: 1072-8368 *

Also Published As

Publication number Publication date
AU2003287824A8 (en) 2004-07-22
AU2003287824A1 (en) 2004-07-22
WO2004058809A2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
WO2004041854A3 (en) Essential novel bacterial polypeptides
EP2434016A3 (en) Expression of mammalian proteins in Pseudomonas fluorescens
WO2003087353A3 (en) Purified polypeptides involved in membrane biogenesis
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis
WO2007093848A3 (en) Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori
AU2002349231A1 (en) Methylotrophic bacterium for the production of recombinant proteins and other products
WO2003102190A3 (en) Bacterial polypeptides involved in viability
WO2004058809A3 (en) Novel essential bacterial polypeptides
WO2003044185A3 (en) Purified polypeptides involved in general metabolism
WO2004081206A3 (en) Novel polypeptides encoded by essential bacterial genes
AU2003285485A1 (en) 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
WO2003025008A3 (en) Bacterial polypeptides involved in protein processing
WO2003025004A3 (en) Purified bacterial polypeptides involved in nucleic acid processing
WO2003027139A3 (en) Novel purified polypeptides involved in membrane biosynthesis
WO2003084987A3 (en) Polypeptides from bacteria and uses thereof
WO2003083099A3 (en) Purified polypeptides involved in protein synthesis and modification
WO2003084986A3 (en) Novel purified polypeptides involved in cellular metabolism
WO2007064865A3 (en) Fabg polypeptides ( 3-oxoacyl- [ acyl-carrier protein ] reductase ) involved in bacterial fatty acid synthesis
WO2004044189A3 (en) Novel purified polypeptides involved in metabolism
WO2003035858A3 (en) Bacterial polypeptides involved in nucleic acid processing
WO2003025006A3 (en) Purified polypeptides involved in co-factor metabolism
WO2003025007A3 (en) Purified polypeptides involved in membrane biosynthesis
WO2003025005A3 (en) Purified bacterial polypeptides involved in protein processing
WO2003087145A3 (en) Purified polypeptides involved in quorum sensing
WO2003085103A3 (en) Purified polypeptides involved in nucleotide hydrolysis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11167924

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 11167924

Country of ref document: US